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AExpression of Mouse Mammary Tumor Virus Envelope Protein Does Not Prevent
Superinfection In Vivo or In Vitro
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Inbred mice expressing endogenous mouse mammary tumor virus envelope proteins can be infected with exogenous
virus, and the mammary tumors that develop in these mice usually have many proviruses integrated in their genomes,
indicating that this virus is not subject to receptor interference. We show here that transgenic mice expressing an exogenous
mouse mammary tumor virus (C3H) envelope protein can still be infected with this virus. Moreover, cultured mammary gland
cells expressing the mouse mammary tumor virus (C3H) envelope protein can be superinfected with pseudotyped viruses
bearing that same protein. Thus cellular expression of the mouse mammary tumor virus envelope protein does not block
superinfection in vivo or in vitro. © 1999 Academic Press
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iINTRODUCTION
Virus entry into cells takes place after the interaction
etween proteins located on the surface of the virion and
n the cell membrane. In the case of retroviruses, the
nvelope protein (Env) consists of two chains. The sur-
ace (SU) protein mediates binding of virions to the cel-
ular receptor molecule, whereas the transmembrane
TM) protein causes fusion of the particles with the cell
embrane, thereby allowing entry into the cell. After
nfection, the two Env chains are expressed from the
ntegrated provirus and are translated and transported to
he cell surface in the same manner as other membrane
lycoproteins.
Cells chronically infected with retroviruses may exhibit
significant decrease in susceptibility to infection with
ther viruses expressing SUs with the same receptor
pecificity. This viral interference is due to interaction of
he Env glycoprotein of the initially infecting virus with the
ellular receptor, which subsequently blocks binding and
nfection by the second virus. The interaction between
he receptor and SU occurs either at the cell membrane
r at intracellular locations (Delwart and Panganiban,
989; Heard and Danos, 1991; Sommerfelt and Weiss,
990; Stevenson et al., 1988).
Viral receptor interference assays have been used in
umerous studies of retroviruses to study receptor us-
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418ge. For example, murine leukemia viruses (MuLV) have
een categorized into six different receptor interference
roups, each using distinct cellular receptors (Chesebro
nd Wehrly, 1985; Cloyd et al., 1985; Miller and Wolgamot,
997; Rein, 1982; Rein and Schultz, 1984). Viral receptor
nterference in vivo may select for novel MuLVs that arise
hrough recombination. In the case of polytropic MuLVs,
t has been shown that recombination between different
ndogenous viruses is required to generate a transform-
ng virus, in part through the acquisition of novel Env
roteins that allow the recombinant virus to bind to
ifferent cellular receptors than the parental viruses from
hich they were derived (Cloyd et al., 1985; Rein, 1982;
toye et al., 1991). Indeed, expression of Env glycopro-
eins encoded by endogenous MuLVs can block infec-
ion, although the precise mechanism by which this pro-
ection occurs is not known (Kozak, 1985; Dandekar et
l., 1987; Limjoco et al., 1993).
Mouse mammary tumor virus (MMTV) is a milk-borne
etrovirus that causes mammary tumors in mice (Nandi
nd McGrath, 1973). MMTV is produced in the mammary
lands of infected females and is transferred via milk to
uckling newborn pups. MMTV infection initially occurs
n B cells (Karapetian et al., 1994), but both B and T cells
ltimately acquire integrated copies of the provirus (De-
aymard et al., 1993; Dzuris et al., 1997; Karapetian et al.,
994). B and T cells are required for the milk-borne
ransmission of MMTV (Beutner et al., 1994; Golovkina et
l., 1992; Held et al., 1993), and both are potential carriers
f virus to the mammary gland (Dzuris et al., 1997). Tumor
nduction occurs when a new copy of the viral genome
ntegrates next to a cellular oncogene, thereby activating
ts transcription in the mammary cell (Nusse, 1988; Pe-
ers, 1991).
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419MMTV(C3H) ENVELOPE PROTEINMMTV uses a superantigen (Sag) protein encoded in
he 39 LTR to establish infection in mice. Sags are pre-
ented by the major histocompatibility class II proteins of
ntigen presenting cells, such as B cells, to CD41 T cells
earing specific Vb chains of the T cell receptor (TCR).
his presentation of Sag causes proliferation of specific
b-bearing T cells when it is recognized as foreign (Choi
t al., 1991) and deletion of such T cells when it is
ecognized as self (Acha-Orbea et al., 1991). Different
roviruses cause the deletion or stimulation of different
lasses of Vb-bearing T cells because they encode Sag
roteins with different C-terminal amino acid sequences
termed the hypervariable region); this region of the Sag
rotein contacts the TCR Vb molecule (Dyson et al., 1991;
rankel et al., 1991; Marrack et al., 1991; Woodland et al.,
991). MMTV is able to initiate lymphoid cell infection
ecause it encodes an Sag. The Sag causes stimulation
f cognate T cells and, as a result, bystander B cell
ivision, setting up a reservoir of infection-competent
ells. The major evidence for this pathway comes from
tudies done with mice lacking Sag-reactive T cells
Golovkina et al., 1992; Held et al., 1993) or B cell-defi-
ient mice (Beutner et al., 1994); both are resistant to
ilk-borne transmission of MMTV.
The initial step of MMTV infection, like other retrovi-
uses, is the binding of the viral SU protein to a specific
ell surface receptor via the viral Env glycoprotein, but
ittle is known about how these proteins interact. There
re mouse strains that express fully functional endoge-
ous MMTVs in mammary gland that develop mammary
umors containing additional MMTV proviruses (Nandi
nd McGrath, 1973). DNA isolated from the clonal tumors
f the best-studied of these strains, GR, usually contains
any new copies of the provirus, indicating that the cells
ere superinfected (Michalides et al., 1978). The endog-
nous Mtv-2 locus that gives rise to the infectious virus
n GR mice still causes tumors in recombinant inbred
ice that lack all other endogenous MMTVs, indicating
hat a polytropic-like recombination is not required for
uperinfection of mammary cells (Morris et al., 1986).
Does MMTV then act like other murine retroviruses
nd exhibit receptor interference? To answer this ques-
ion, we examined the ability of endogenously expressed
MTV to interfere both in vivo and in vitro with the
ubsequent infection by exogenous viruses expressing
he Env glycoprotein.
RESULTS AND DISCUSSION
As a first step to determining whether MMTV exhibited
uperinfection interference in vivo, we tested whether a
train of mice bearing an infectious, milk-transmitted
lone of MMTV that encodes the MMTV(C3H) Env pro-
eins, termed HYB PRO (Golovkina et al., 1994; Shackle-
ord and Varmus, 1988), was able to be infected with an
xogenous virus that has a highly homologous Env (10/ a58 amino acid differences in the mature SU protein),
ermed LA virus (Golovkina et al., 1997). HYB PRO trans-
enic mice produce MMTV levels roughly equivalent to
hat produced by MMTV(C3H)-infected mice (Fig. 1)
Golovkina et al., 1994; Dzuris et al., 1997). We used a
ecently developed assay that tests for the first step of
MTV or MuLV infection of B cells (Ardavin et al., 1997).
his assay measures increased expression of the lym-
hocyte activation marker CD69 in B cells shortly after
nfection (Ardavin et al., 1997). It has been proposed that
MTV or MuLV binding to B cells causes this activation
hrough binding to their cellular receptors (Ardavin et al.,
997).
HYB PRO, C3H/HeN MMTV1, or control C3H/HeN
ice received footpad injections of LA virus, and 18 h
fter injection, the cells of the draining popliteal lymph
ode were stained for CD69. The contralateral draining
ymph node served as the control. If the LA virus infected
he B cells, the lymphocytes in the draining lymph node
hould become activated and a large percentage should
xpress CD69, whereas mice that were resistant to virus
hould have no activated B cells. C3H/HeN MMTV1 mice
ere also tested; because only ;5–20% of the B cells
re infected during milk-borne transmission of the virus
Golovkina et al., 1997), these mice should still have been
usceptible to exogenous virus infection even if there
as superinfection interference. As shown in Table 1,
YB PRO, C3H/HeN MMTV1, and C3H/HeN mice had
quivalent increases in the percentage of CD691 cells in
he draining lymph node, indicating that B cells from all
hree types of mice were equally stimulated by virus.
hus although the HYB PRO B cells expressed high
evels of the env gene and protein, they were able to be
nfected by exogenous virus.
We next produced transgenic animals that expressed
FIG. 1. Envelope expression in HYB PRO and MMTV(C3H)-infected
ice. Crude protein extract (150 mg) from the pooled mesenteric and
opliteal lymph nodes of 2-month-old HYB PRO(HP) and C3H/HeN
MTV1 (MMTV1) mice were subjected to SDS–PAGE and Western blot
nalysis using a polyclonal anti-MMTV antiserum. As controls, 150 mg
f lymph node extracts from an uninfected C3H/HeN mouse (MMTV2)
nd an 8-month-old tumor-bearing C3H/HeN MMTV1 animal [MMTV1
T)], as well as the tumor from this animal (tumor), was also analyzed.
imilar results were seen with spleen extracts (not shown).noninfectious form of HYB PRO. This virus, named HYB
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420 DZURIS ET AL.RO/Cla, encodes an exogenous MMTV(C3H) Env gly-
oprotein but has a stop mutation in the open reading
rame encoding the Sag (Fig. 2A and Golovkina et al.,
995). Expression of this transgene should produce an
nv glycoprotein that is classically involved in receptor
nterference. At the same time, the presence of the stop
utation in the sag prevented deletion of T cells bearing
he specific Vb chain of the T cell receptor (Vb14) that are
eeded for a successful infection by a subsequent ex-
genous MMTV(C3H) bearing the same Sag.
The presence of the transgene as well as the endog-
nous MMTV provirus in C3H mice was detected by
outhern blot analysis performed on DNA isolated from
pleen (Fig. 3), as previously described (Golovkina et al.,
994). Expression of the transgene was determined by
Nase protection analysis of RNA isolated from lactating
TABLE 1
HYB PRO Transgenic and C3H/HeN MMTV1 Mice Can Be
Superinfected with MMTV LA
Mouse strain
CD69 Positive (%)
Draining lymph
node
Control lymph
node
Fold
increase
3H/HeN 49.2 6 6.6 (4) 21.6 6 3.7 2.3
3H/HeN (MMTV1) 38.5 6 3.4 (4) 17.5 6 2.1 2.2
YB PRO 51.6 6 7.8 (3) 23.0 6 1.5 2.2
Note. Mice were injected with MMTV LA in one hind footpad or
uffer in the contralateral footpad and sacrificed 18 h later. The draining
ymph nodes were removed, lymphocytes were stained with FITC-
onjugated anti-CD69 antibody and subjected to FACS analysis. The
umber of mice analyzed is given in parentheses. Shown are the
verage value and deviation from the mean.
FIG. 2. (A) Diagram of the parental MMTV(HYB PRO) and the MMTV
n the open reading frame that encodes the virus Sag (Golovkina et a
Shackleford and Varmus, 1988). This mutation allows for the expressio
he fragments generated by PstI–BglII digestion and the probe used for
ransgene RNA in HYB PRO/Cla mice. RNase T1 protection analysis of 4
ammary glands of HYB PRO/Cla (HPCla) mice was performed as
MTV(C3H) RNA in the LMG of a C3H/HeN MMTV1 (C3H1) mouse aHPCla1). The arrow denotes the protected fragment indicative of virus transcnd virgin mammary glands of transgenic females, using
probe that was specific to the 39 LTR of MMTV(C3H)
Golovkina et al., 1994). Figure 2B shows the presence of
low level of expression of MMTV(HYB PRO/Cla) RNA in
he virgin mammary gland of transgenic animals that
ncreased during lactation. Although these mice ex-
ressed the transgene, the HYB PRO/Cla transgenic
ice did not exhibit deletion of their Vb14-bearing T cells
t 2 months of age, indicating that the Sag encoded by
he transgene was not functional (Table 2 and Golovkina
t al., 1995). After 4 months of age, these mice begin to
how deletion of Sag-cognate T cells due to a recombi-
ation between an endogenous MMTV and the trans-
ene that repairs the mutation (Golovkina et al., 1995).
owever, as shown below, this recombination does not
ffect the deletion that occurs after milk-borne infection
f these mice by a second virus.
The effect of the MMTV(HYB PRO/Cla) transgene on
usceptibility to infection with milk-borne MMTV(C3H)
xogenous virus was tested. Newborn transgenic mice
ere foster-nursed on female C3H mice infected with
xogenous MMTV(C3H). We first tested whether the
resence of the transgene prevented infection of B lym-
hocytes by MMTV(C3H), using the sensitive readout of
b14
1–T cell deletion; all analyses were done with mice
t ,2 months of age before the recombination with
ndogenous virus could be detected. As shown in Table
, HYB PRO/Cla transgenic and C3H/HeN mice that
ursed on the same C3H/HeN MMTV1 mother showed
quivalent deletion of their Vb14-bearing T cells. Thus B
ell infection and Sag presentation were normal even in
he presence of endogenous Env production.
To determine whether transgene expression within the
ammary gland prevented superinfection, the HYB PRO/
RO/Cla) transgene (HYB PRO/Cla) containing the stop codon mutation
). The HYB PRO molecular clone encodes the MMTV(C3H) env gene
al structural proteins but renders the virus noninfectious. The sizes of
ern blot analysis are also shown. P indicates PstI; B, BglII. (B) Level of
f total cellular RNA isolated from the virgin (VMG) and lactating (LMG)
usly described (Golovkina et al., 1994). Also shown is the level of
a HYB PRO/Cla mouse foster-nursed on a C3H/HeN MMTV1 mother(HYB P
l., 1994
n of vir
South
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previo
nd inription.
C
b
t
M
R
c
H
M
a
P
m
o
1
B
t
M
w
f
m
f
b
c
i
s
H
e
n
v
E
b
t
i
p
w
m
f
l
a
m
t
m
M
u
e
n
s
p
a
m
d
w
o
s
v
f
a
t
t
q
C
H
H
H
C
C
j
H
t
N
c
i
c
E
p
421MMTV(C3H) ENVELOPE PROTEINla mice were allowed to mature to adulthood and force
red. RNA isolated from the lactating mammary gland of
hese mice indicated that they were superinfected with
MTV(C3H) virus, because they produced more viral
NA than did uninfected HYB PRO/Cla females (Fig. 2B,
ompare HPCla with HPCla1 lanes). Moreover, 9 of 10
YB PRO/Cla females foster-nursed on C3H/HeN
MTV1 mothers developed mammary gland tumors with
n average latency of 185 days, although uninfected HYB
RO/Cla females never developed mammary gland tu-
ors; this incidence and latency were similar to that
bserved for C3H/HeN MMTV1 mice (Golovkina et al.,
993). Southern blot analysis was carried out on PstI–
glII-digested tumor DNA using a probe that allowed us
FIG. 3. Detection of exogenous MMTV(C3H) proviral DNA in mam-
ary gland tumors of HYB PRO/Cla mice. DNA from tumors that
eveloped in transgenic MMTV(C3H)-infected mice (T) was digested
ith PstI and BglII and subjected to Southern blot analysis as previ-
usly described (Golovkina et al., 1994). Because of a polymorphic PstI
ite, the transgene and MMTV(C3H), as well as the endogenous pro-
iruses, generate different-sized fragments (Fig. 2A). Splenic DNAs
rom HYB PRO/Cla transgenic and C3H/HeN nontransgenic (NT) mice
re included as controls. Hybridization was performed using a probe
hat detected endogenous MMTV sequences (ENDOG.; 3.0 and 2.1 kb),
he HYB PRO/Cla transgene (TRANS; 3.0 and 2.3 kb), and newly ac-
uired exogenous MMTV(C3H) (EXOG.; 1.5 kb).
TABLE 2
Deletion of Cognate T Cells in HYB PRO/Cla Mice Infected
with MMTV(C3H)
Mousea Vb141/CD41 T cells
3H/HeN (MMTV2) 7.7
YB PRO/Cla 7.8
YB PRO/Cla f. C3H/HeN (MMTV1) 3.0
YB PRO/Cla f. C3H/HeN (MMTV1) 4
3H/HeN f. C3H/HeN (MMTV1) 2.9
3H/HeN f. C3H/HeN (MMTV1) 3.4
a Peripheral blood lymphocytes from 2-month-old mice were sub-
ected to FACS analysis. The HYB PRO/Cla transgenic and the C3H/meN mice were foster-nursed on the same C3H/HeN MMTV1 mother.o distinguish newly integrated copies of exogenous
MTV(C3H) from the endogenous MMTV proviruses, as
ell as the HYB PRO/Cla transgene (Fig. 2A). As shown
or the three tumor DNAs isolated from the transgenic
ice that nursed on exogenous MMTV(C3H)-infected
emales, newly integrated exogenous virus, as indicated
y the presence of the 1.5-kb band, was acquired in all
ases (Fig. 3).
Although it was possible that levels of Env expressed
n the HYB PRO/Cla mice were not sufficient to prevent
uperinfection, taken together with the results from the
YB PRO transgenic mice, these results indicated that
xpression of the Env proteins encoded by MMTV did
ot interfere with infection by exogenous MMTV(C3H) in
ivo.
We also used an in vitro approach to show that MMTV
nv-expressing cells could be superinfected by virus
earing the same Env protein. Many studies have shown
hat MuLV-infected tissue culture cells cannot be super-
nfected with viruses bearing the same or similar SU
roteins. Indeed, many of the MuLV interference groups
ere defined by such in vitro studies (Miller and Wolga-
ot, 1997).
Several tissue culture cell lines were tested in inter-
erence assays. A normal mouse mammary gland cell
ine, NMuMG, and two different clones of NMuMG (Cl1
nd Cl4) that were stably transfected with the HYB PRO
olecular clone (Dzuris et al., 1997), as well as an addi-
ional uninfected mammary gland cell line, HC11, and a
ammary tumor cell line that is highly infected with
MTV(C3H), Mm5MT (.50 copies of the provirus), were
sed. Neither NMuMG nor HC11 cells transcribe any
ndogenous proviruses (data not shown), and therefore
either produced viral proteins (Fig. 4, lane 1, and not
hown, respectively). To examine the level of Env glyco-
rotein expression in the transfected cells, Western blot
nalysis was performed on total cell extracts using a
FIG. 4. Western blot analysis of Env glycoprotein in HYB PRO-
ransfected NMuMG cells. Total cellular extracts (100 mg) from normal
MuMG, from two independently transfected HYB PRO NMuMG
lones (Cl1 and Cl4), and from Mm5MT mammary tumor cells line were
mmunoblotted using a monospecific, polyclonal goat anti-gp52 poly-
lonal antiserum, as previously described (Golovkina et al., 1994).
xtracts were obtained from cells grown in the absence (2dex) or
resence (1dex) of 0.5 mM dexamethasone for 24 h.onospecific anti-MMTV SU serum (Fig. 4). Both Cl1 and
C
g
e
s
t
m
e
l
t
s
(
f
p
w
t
i
u
m
i
w
d
1
t
w
C
c
n
p
m
(
l
c
i
w
i
a . (B) M
422 DZURIS ET AL.l4 expressed high levels of the MMTV Env glycoprotein
p52, as well as the Env precursor protein gp73, and
xpression in all the cells was inducible by dexametha-
one (Fig. 4). Env protein levels in Cl1 were greater than
hose in Cl4 and were similar to those found in the
ammary tumor cell line Mm5MT. The difference in
xpression between Cl1 and Cl4 was also seen in the
evel of expression of RNA and virus particles shed into
he culture media (data not shown). We have previously
hown that Cl1 produces infectious virus particles
Dzuris et al., 1997).
Superinfection of the NMuMG and HYB PRO-trans-
ected NMuMG cell lines was then examined using a
seudotyped retroviral vector. The pseudotyped virions
ere created by transient transfection of 293T cells with
he plasmids pHIT111, which expresses an RNA contain-
ng the packaging signals for MuLV and a lacZ gene
FIG. 5. (A) MMTV pseudovirus titer on NMuMG, Cl1, Cl4, HC11, and Mm
as used to infect the different cell lines grown in the presence (1DEX
n the presence of dexamethasone in this experiment). The cells were
ctivity. This experiment was repeated three times with similar resultsnder the control of the cytomegalovirus (CMV) pro- poter, pHIT60 (Soneoka et al., 1995), containing the cod-
ng regions of the MuLV gag and pol genes, and pENV,
hich expresses the MMTV(C3H) env gene and was
erived from the HYB PRO construct (Golovkina et al.,
998). Supernatants from the transfected 293T cells con-
aining pseudovirions bearing MMTV(C3H) Env proteins
ere then used to infect the HC11, Mm5MT, NMuMG,
l1, and Cl4 cells. Infection levels were determined by
ounting the number of b-galactosidase-positive colo-
ies that arose after 3–4 days of culture.
As shown in Fig. 5A, infection of NMuMG cells gave
seudovirus titers of ;5 3 104 Lac Z-forming units (LFU)/
l. The pseudovirus titer was slightly lower on the Cl4
;3.5 3 104 LFU/ml) and Cl1 (;2.8 3 10
4 LFU/ml) cell
ines. However, dexamethasone treatment of all of these
ell lines did not significantly alter their ability to be
nfected, although all the MMTV-expressing cell lines
ells. MMTV pseudovirus produced in transiently transfected 293T cells
ence (2DEX) of 0.5 mM dexamethasone (HC11 cells were only tested
ated for an additional 3–4 days and then stained for b-galactosidase
MTV pseudovirus titer on different cell lines.5MT c
) or abs
incubroduced at least 10-fold more SU protein in the pres-
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423MMTV(C3H) ENVELOPE PROTEINnce of hormone (Fig. 4). Moreover, the HC11 normal
ammary gland cell line and the MMTV(C3H)-infected
ammary tumor line Mm5MT showed equivalent levels
f infection (;0.7 and ;0.5 3 104 LFU/ml, respectively),
nd the ability to be infected by the pseudotyped parti-
les was not altered in Mm5MT cells when the cells
ere treated with dexamethasone. Thus these results
howed that prior expression of the Env glycoproteins in
he cultured cell lines did not inhibit infection by the
MTV Env-pseudotyped virion.
Although there was a small decrease in the number of
nfected Cl1 and Cl4 cells relative to NMuMG, receptor
nterference is commonly defined by infection level dif-
erences of 2 logs. The different infection titers on
MuMG, Cl1, and Cl4 cells may be due in part to varia-
ions in cell division times or to other nonspecific factors.
ndeed, we found that there was a wide variation in the
bility of the pseudotyped particles to infect different
ammary cell lines (NMuMG and HC11; Figs. 5A and
B), as well as cell lines derived from different mouse
issues (compare titers on fibroblast lines BALB3T3 and
IH3T3, hepatoma line HEPA) and from monkey kidney
MTVR-transfected CV1 cells) (Fig. 5B). All of these cell
ines expressed approximately equal levels of the re-
ently cloned MMTV receptor (Golovkina et al., 1998), at
east at the RNA level (not shown).
These results indicated that despite the intracellular
xpression of Env, there were receptors available on the
ell surface capable of interacting with the SU on exog-
nously added virus. Although the transfected cell lines
xpressed at least as much Env as the Mm5MT mam-
ary tumor cell line that contains many additional copies
f MMTV(C3H), it was possible that this level of expres-
ion was not sufficient to block receptor at the surface.
o determine whether receptor could be blocked by
arge amounts of Env protein, we tested whether a bac-
erially produced histidine-tagged SU protein would in-
ibit infection by the MMTV Env pseudotyped virions. As
hown in Table 3, the addition of 4 mg/ml of this protein
o the culture medium blocked infection of the NMuMG,
l1, and Cl4 cell lines by $84%, whereas the addition of
TABLE 3
Blocking of Pseudotype Infection with Recombinant SU Protein
Cell line LFU/mla
LFU/mla
4 mg/ml
SU-his
0.4 mg/ml
SU-his
5 mg/ml
Tva-his
Anti-MMTV
(1 mg/ml)
MuMG 7327 366 2639 9228 0
I1 5692 747 4039 2798 0
l4 4357 684 4881 3679 0
a LacZ1-forming units (31023).0-fold lower levels of the recombinant MMTV SU protein lad little or no affect on the pseudotype titers. The
ddition of an equivalent amount of an unrelated histi-
ine-tagged protein (Tva, the subgroup A avian sarcoma
nd leukosis virus receptor) had little or no effect on
nfection levels, whereas polyclonal goat anti-MMTV an-
isera completely blocked infection (Table 3).
Thus in contrast to other murine retroviruses, the pro-
ection from superinfection of a retrovirus that uses the
ame cellular receptor for cell entry does not occur with
he MMTV(C3H) exogenous virus. The expression of the
MTV Env-bearing transgene did not prevent or dimin-
sh the infection in vivo on challenge with an infectious
MTV. Additionally, transduction of an MMTV-trans-
ected mammary gland cell with an MMTV-Env
seudotyped virus occurred in vitro. Although the titer of
seudovirus infection was slightly diminished in some
ells expressing a higher level of Env glycoprotein, the
ower titer achieved does not correlate with the signifi-
ant inhibition of infection seen in interference assays
ith murine retroviruses of the same interference group
Miller and Wolgamot, 1997). Indeed, the variation in virus
iter appeared to be inherent to the clonal isolates, be-
ause no difference in pseudotype titer was observed
fter dexamethasone induction of Env protein production
n the individual cell lines. For example, a mammary
umor cell line that expressed large amounts of MMTV
U protein (Mm5MT) and a normal mammary cell line
hat expressed no MMTV proteins (HC11) were infected
o equivalent levels, although both showed pseudovirus
iters ;10-fold lower than that seen with another murine
ammary cell line, NMuMG.
These results indicate that the cellular receptor used
y MMTV for entry into cells displays unique properties
n its interaction with the Env glycoprotein that are not
een with other murine retroviruses. MMTV is a type B
etrovirus, and its intracellular assembly is thought to
iffer from that of the more commonly studied type C
etroviruses. For example, immature MMTV particles are
een not only at the cell membrane, where budding
ccurs, but also in the intracellular compartment. Thus it
s possible that the receptor and MMTV Envs traffic
ifferently within the cell and that intracellular SU cannot
revent receptor from appearing at the surface, as is
hought to occur with some other retroviruses.
Alternatively, it is possible that the MMTV SU does not
ind to its cellular receptor when expressed endog-
nously or that this binding is not of sufficiently high
ffinity to prevent dissociation at the cell surface. If the
U–receptor dissociation constant is high, then exoge-
ous virus would be able to bind and receptor interfer-
nce by an endogenously expressed protein would not
ccur. Only when we added very high levels of the
acterially produced Env were we able to block infection
y the pseudotyped virus; this indicates that binding of
MTV to its receptor is of low affinity and requires aevel of Env expression much higher than would normally
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424 DZURIS ET AL.ccur to achieve interference. Our recent identification of
n MMTV receptor will allow us to study the SU–receptor
nteractions at the molecular and cellular level and to
etter understand the lack of interference (Golovkina et
l., 1998). It is also possible that the level of receptor on
he surface of cells is too high to be saturated with the
mount of Env protein produced in virus-infected cells.
ecause Mm5MT cells, which have .50 integrated pro-
iral copies can still be infected with pseudotyped virus,
t appears that functional receptor interference cannot be
chieved in MMTV-infected cells.
Although endogenous MMTVs do not prevent super-
nfection at a cellular level, they do protect animals
gainst infection. We have previously shown that MMTV
nfection requires the interaction of MMTV Sag with a
opulation of T lymphocytes bearing a specific Vb T cell
eceptor. Mice lacking this population of Vb specific
earing T cells are not readily infected with the strain of
MTV that expresses the Sag that reacts with that spe-
ific T cell population (Golovkina et al., 1992). Thus the
resence of endogenous MMTV and the subsequent
xpression of endogenous sags in mice protects them
gainst exogenous viral infection by a strain of MMTV
hat encodes a homologous sag. Although the mecha-
ism by which this genetic resistance to viral infection
ccurs is different from that seen with MuLV, the func-
ional consequences, protection from infection by exog-
nous virus, are identical. However, it appears that an
MTV encoding a different Sag, but expressing a SU
rotein highly homologous to endogenous SU, retains
he ability to avoid the receptor interference mechanism
f host resistance exhibited by other retroviruses and
an still infect the host.
MATERIALS AND METHODS
ice
C3H/HeN MMTV2 and C3H/HeN MMTV1 mice from
olonies of germ-free-derived, defined-flora animals
ere purchased from the National Institutes of Health
Frederick Cancer Research Facility, Frederick, MD).
ransgenic mice bearing the HYB PRO and HYB PRO/Cla
onstruct have been previously described (Golovkina et
l., 1994, 1995, 1997). MMTV-infected mice were exam-
ned weekly by palpation for mammary tumors. Tumor-
earing mice were sacrificed, and DNA isolated from a
ortion of each tumor was subjected to Southern blot
nalysis as described below.
ACS analysis
Peripheral blood lymphocytes were isolated and
tained as previously described (Golovkina et al., 1992).
ITC-coupled monoclonal antibodies against the Vb-14
CR chain were purchased from PharMingen Inc. (San
iego, CA). Anti-CD4 antibodies (GK 1.5) coupled to PE (ere purchased from Life Technologies (Grand Island,
Y). An FACscan (Becton Dickinson, Mountain View, CA)
lowcytometer and CellQuest software program were
sed for FACS analysis.
ootpad injections
Fifty microliters of MMTV LA virus stock prepared as
reviously described (Golovkina et al., 1997) was in-
ected into the footpad of the various mice, and 18 h after
njection, the mice were sacrificed. Lymphocytes were
solated from the popliteal lymph nodes, stained with
ITC-conjugated anti-CD69 antibodies (PharMingen,
nc.) and subjected to FACS analysis.
outhern blot analyses
Mammary gland tumors were excised from the sur-
ounding normal tissue, and DNA was isolated by pro-
einase K–SDS, followed by phenol–chloroform extrac-
ion and ethanol precipitation. Then 20 mg of each DNA
as digested with PstI and BglII according to the man-
facturer’s instructions (GIBCO BRL, Gaithersburg, MD)
nd electrophoresed on 0.8% agarose gels. After transfer
o nitrocellulose, the blots were hybridized with the 32P-
abeled probe shown in Fig. 1A that distinguishes the
xogenous and endogenous proviruses, as previously
escribed (Golovkina et al., 1994).
Nase T1 protection assays
A 340-p Sau3A fragment from the Sag hypervariable
egion of the MMTV(C3H) LTR was used as a probe for
Nase T1 protection assays, as previously described
Golovkina et al., 1994).
ell culture
The normal mammary gland cell NMuMG and MMTV
HYB PRO)-transfected NMuMG (Cl1 and Cl4) were cul-
ured in DMEM supplemented with 10% FCS and 10
g/ml insulin. The Cl1 cell line had been previously
escribed (Dzuris et al., 1997). The 293T, Mm5MT, HEPA,
IH3T3, BALB3T3, and CV1 cells were cultured in DMEM
upplemented with 10% FCS. The HC11 cell line was
ultured in RPMI supplemented with 10% FCS, 10 mg/ml
nsulin, and 10 ng/ml epidermal growth factor.
seudotyped MuLV virion production and virus
nfections
The pseudotyped MLV viruses were created by tran-
ient transfection of 293T cells with plasmids pHIT111
containing the MLV packaging sequence and the lacZ
ene), pHIT60 (containing the MLV gag-pol genes under
he control of the CMV promoter), and pENV [containing
he MMTV(C3H) env gene under the control of the CMV
romoter] and used for infection as previously describedGolovkina et al., 1998). The virus titer was determined by
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425MMTV(C3H) ENVELOPE PROTEINultiplying the total number of b-galactosidase-positive
olonies by the dilution factor and are reported as LFU/
l. His-tagged proteins were added to the cell cultures
0 min before the addition of the pseudotyped viruses at
he concentrations described in Table 3.
estern blot analysis
Total cellular protein was extracted from cells or tis-
ues using lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM
aCl, 1 mM EDTA, 0.1% SDS, 1.0% Nonidet P-40, and 1.0%
riton X-100). Cellular protein (100 mg) was separated by
0% SDS–PAGE and Western blot analysis was per-
ormed, as previously described (Dzuris et al., 1997),
sing goat anti-MMTV or anti-gp52 (SU) (NCI/BCB Re-
ository, Quality Biotech Inc., Camden, NJ).
is-tagged gp52 purification
The gp52 sequences were cleaved from a plasmid
ontaining the MMTV(C3H) env gene (Majors and Var-
us, 1983) and ligated in frame into the pET vector
Novagen, Inc.). The His-tagged protein was purified first
n a nickel agarose column, according to the manufac-
urer’s instructions, and then on a anti-gp52 Sepharose
olumn. The His-tagged Tva protein was a gift from Paul
ates (Baillet et al., 1999).
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